AMPGZ 8-K Filed 2026-08-13 New authorization

AmpliTech authorizes $10M share repurchase program

Board approves 24-month buyback as company reports strong Q2 revenue growth and improved margins

Authorization$10M
MechanismNot specified

What the filing says

AmpliTech Group, Inc. announced on July 7, 2026, that its Board of Directors has authorized a stock repurchase program permitting the company to repurchase up to $10 million of its outstanding common stock over the next 24 months. The authorization is subject to market conditions, applicable law and other considerations, with no specific execution mechanism disclosed in the filing.

The share buyback authorization comes as AmpliTech reported strong operational momentum in the second quarter of 2026. Q2 revenue reached $8.07 million, up 50.9% sequentially from Q1 and reflecting significant gross margin expansion to 27.9% from 7.8% in the prior-year quarter. The company also closed a Series A rights offering on July 22, 2026, raising approximately $20.12 million in net proceeds, which materially strengthened its balance sheet and liquidity position.

As of June 30, 2026, AmpliTech reported cash and marketable securities of approximately $12.95 million, total current assets of $31.25 million, and working capital of $22.93 million. The company stated it believes it will be able to meet obligations and capital requirements for at least the next 12 months based on existing cash, working capital, and forecasted operations and cash flows.

On July 7, 2026, the Board of Directors authorized a stock repurchase program of up to $10 million of the Company's outstanding common stock over the following 24 months, subject to market conditions, applicable law and other considerations. — AmpliTech Group, Inc. 8-K filing  ·  View on SEC EDGAR →

What this means

The $10 million repurchase authorization represents an opportunistic capital allocation tool for AmpliTech at a company with approximately $46.75 million in total stockholders' equity as of June 30, 2026. The 24-month window provides management flexibility to execute purchases based on market conditions and the company's strategic priorities. With recent improved operational performance, revenue momentum across multiple business segments, and a freshly strengthened balance sheet from the Series A rights offering, the company is signaling confidence in its business trajectory. The buyback, if fully executed, would reduce share count and could support long-term per-share metrics, though actual execution will depend on the company's cash generation, capital needs, and prevailing share prices.

Frequently asked questions

What is the size and duration of AmpliTech's new repurchase program?
The Board authorized repurchase of up to $10 million of common stock over the following 24 months from July 7, 2026. The program is subject to market conditions, applicable law and other considerations, meaning management has flexibility on timing and pace of execution.
Why did AmpliTech authorize a buyback at this time?
The company closed a Series A rights offering in July 2026, raising approximately $20.12 million in net proceeds, which strengthened its balance sheet and liquidity position. The authorization reflects management's confidence in the business, given strong Q2 sequential revenue growth of 50.9% and improving gross margins, along with diversified revenue opportunities across 5G, SATCOM, defense, and semiconductor markets.
What mechanism will AmpliTech use to execute the buyback?
The filing does not specify the execution mechanism. The company may conduct open-market purchases, utilize a 10b5-1 plan, or employ other methods permitted under securities laws, subject to market conditions and applicable regulations.
How does this $10M authorization compare to AmpliTech's financial position?
As of June 30, 2026, AmpliTech had approximately $12.95 million in cash and marketable securities and $46.75 million in total stockholders' equity. A $10 million buyback would represent approximately 77% of cash on hand or about 21% of equity, a material but not dominant capital allocation.
What was AmpliTech's operating performance in Q2 2026?
Q2 2026 revenue reached $8.07 million, up 50.9% sequentially and with gross profit increasing 161.2% year-over-year. Gross margin expanded to 27.9% from 7.8% in Q2 2025, though the company posted a net loss of $3.09 million due to increased R&D investment and operating expenses.
Does the authorization have any restrictions on share count or price limits?
The filing does not disclose restrictions on minimum or maximum share prices, or targets for total shares repurchased. Execution is left to management's discretion subject to market conditions and applicable law.
authorization small-cap 24-month-program rf-microwave-semiconductor post-offering
Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.